Hematology
Latest News
Delayed umbilical cord clamping improves outcomes in very preterm infants
Delayed clamping reduced risk of death or disability by 17% at 2 years of age.
Conference Coverage
Beta-thalassemia gene therapy achieves lasting transfusion independence
“Seeing the restoration of iron metabolism, it really takes us a step closer to really thinking the term ‘cure’ might truly apply.”
From the Journals
Apixaban outmatches rivaroxaban for VTE in study
These real-world findings may guide selection of initial anticoagulant therapy, according to authors of the paper.
Latest News
Risk-based antenatal type-and-screen blood testing safe and economical
“In a year of selective type and screen, we saw a 51% reduction in costs related to type and screen, and a 38% reduction in overall transfusion-...
From the Journals
Antithrombotic therapy not warranted in COVID-19 outpatients
In stable patients with COVID-19, use of aspirin or apixaban did not reduce the rate of the composite of all-cause mortality, thromboembolism, MI...
From the Journals
Rivaroxaban’s single daily dose may lead to higher bleeding risk than other DOACs
Corroborating previous studies, Iceland researchers report that rivaroxaban poses the highest risk of GI bleeding, compared with other DOACs.
Latest News
Unexpected thrombocytosis could flag occult cancer
The risk was highest (23.3 times) for ovarian cancer. The risk was 3.8 times higher for pancreatic cancer and 3.5 times higher for cervical cancer...
Latest News
CVST after COVID-19 vaccine: New data confirm high mortality rate
“This is the biggest series, and as an international series, it gives a broader perspective from a larger range of countries.”
From the Journals
Study gives bleeding risk estimates for VTE patients on anticoagulants
New research provides best available estimates of long-term bleeding risk with different anticoagulants, authors say.
Latest News
Iron deficiency in pregnancy is common, yet many aren’t being screened for it
Researchers found that only 59.4% of pregnant persons received an iron test, and 71% of these tests were ordered during the first trimester, when...
From the Journals
Sickle cell disease, trait may up risk for poor COVID outcomes
Even those who carry just one copy of the sickle cell gene – the carrier status for sickle cell disease – appeared to be at heightened risk.